SCHEMBL2648873

SCHEMBL2648873

CCSc1ccc(-c2nc(-c3ccc(Cl)cc3)[nH]c2-c2ccncc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 16/20 0.73
MAPK12 P53778 16/20 0.73
MAPK11 Q15759 16/20 0.73
MAPK14 Q16539 16/20 0.73
GCGR P47871 13/20 0.73
RAF1 P04049 5/20 0.67
MAPK9 P45984 3/20 0.58
PRKD3 O94806 2/20 0.58
MAP4K4 O95819 2/20 0.58
FRK P42685 2/20 0.58
CSNK1A1 P48729 2/20 0.58
CSNK1D P48730 2/20 0.58
GSK3B P49841 2/20 0.58
PRKD2 Q9BZL6 2/20 0.58
CLK4 Q9HAZ1 2/20 0.58
LCK P06239 1/20 0.58
RET P07949 1/20 0.58
ALOX5 P09917 1/20 0.58
PRKACA P17612 1/20 0.58
RPS6KB1 P23443 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6606315 0.88 MAPK11 (0.76) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6466495 0.86 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2649730 0.85 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6471005 0.85 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL5921859 0.80 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6469111 0.80 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6465608 0.80 MAPK13 (0.81) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2647350 0.80 GCGR (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6469126 0.79 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6470896 0.79 MAPK13 (0.86) MAPK13MAPK12MAPK11MAPK14GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0959886-A4 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO INC (US) 2001-05-02 EP claimed
EP-0959886-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS Merck & Co., Inc. (US) 1999-12-01 EP claimed
WO-1998022109-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO., INC. (US) 1998-05-28 WO claimed
EP-0959886-A4 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO INC (US) 2001-05-02 EP disclosed
EP-0959886-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS Merck & Co., Inc. (US) 1999-12-01 EP disclosed
US-5880139-A TREATING DIABETES, OBESITY, HYPERTENSION, CACHEXIA MERCK & CO., INC. (US) 1999-03-09 US disclosed
WO-1998022109-A1 TRIARYL SUBSTITUTED IMIDAZOLES AS GLUCAGON ANTAGONISTS MERCK & CO., INC. (US) 1998-05-28 WO disclosed